Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[These data demonstrate elevated expression of COX-2 in a high percentage of high-grade bladder carcinomas, suggesting a possible role of COX-2 in the progression of bladder urothelial carcinoma and supporting its potential as a therapeutic target in human bladder carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP198040.RAbfRt7D0ypW4Eah-tTsoH8IBxwwkmQVdh1IxE0YFMvlw130_assertion description "[These data demonstrate elevated expression of COX-2 in a high percentage of high-grade bladder carcinomas, suggesting a possible role of COX-2 in the progression of bladder urothelial carcinoma and supporting its potential as a therapeutic target in human bladder carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP198040.RAbfRt7D0ypW4Eah-tTsoH8IBxwwkmQVdh1IxE0YFMvlw130_provenance.
• NP369387.RAVoYs_BVFHWD9aN9tiq3T1cB1Boqd85Ou3Ti_0-u6b1k130_assertion description "[These data demonstrate elevated expression of COX-2 in a high percentage of high-grade bladder carcinomas, suggesting a possible role of COX-2 in the progression of bladder urothelial carcinoma and supporting its potential as a therapeutic target in human bladder carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369387.RAVoYs_BVFHWD9aN9tiq3T1cB1Boqd85Ou3Ti_0-u6b1k130_provenance.
• NP568626.RAGayFrzto9muBOoCTKuq6wkKidiZ9uQbR-Y9G0dDIgwU130_assertion description "[These data demonstrate elevated expression of COX-2 in a high percentage of high-grade bladder carcinomas, suggesting a possible role of COX-2 in the progression of bladder urothelial carcinoma and supporting its potential as a therapeutic target in human bladder carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP568626.RAGayFrzto9muBOoCTKuq6wkKidiZ9uQbR-Y9G0dDIgwU130_provenance.
• NP573601.RAVHfmpj3b_zbQoD0bAjyLOcwYC9hxProEhaoEfzc7dQY130_assertion description "[These data demonstrate elevated expression of COX-2 in a high percentage of high-grade bladder carcinomas, suggesting a possible role of COX-2 in the progression of bladder urothelial carcinoma and supporting its potential as a therapeutic target in human bladder carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573601.RAVHfmpj3b_zbQoD0bAjyLOcwYC9hxProEhaoEfzc7dQY130_provenance.
• NP288085.RA4mSUwifAN6267rXu2k9XkjE8XNfmW_5sapGi-2lHs2k130_assertion description "[These data demonstrate elevated expression of COX-2 in a high percentage of high-grade bladder carcinomas, suggesting a possible role of COX-2 in the progression of bladder urothelial carcinoma and supporting its potential as a therapeutic target in human bladder carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288085.RA4mSUwifAN6267rXu2k9XkjE8XNfmW_5sapGi-2lHs2k130_provenance.
• NP288088.RAw-mYEg_F-kY2m1KTQvmUtkYB8jPiVY73hZVG9hq0l2E130_assertion description "[These data demonstrate elevated expression of COX-2 in a high percentage of high-grade bladder carcinomas, suggesting a possible role of COX-2 in the progression of bladder urothelial carcinoma and supporting its potential as a therapeutic target in human bladder carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288088.RAw-mYEg_F-kY2m1KTQvmUtkYB8jPiVY73hZVG9hq0l2E130_provenance.
• NP288080.RAQkQv11lmxd6oJGaFc8LLWTb3FqbcJErRDbjoxUkK9-c130_assertion description "[These data demonstrate elevated expression of COX-2 in a high percentage of high-grade bladder carcinomas, suggesting a possible role of COX-2 in the progression of bladder urothelial carcinoma and supporting its potential as a therapeutic target in human bladder carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288080.RAQkQv11lmxd6oJGaFc8LLWTb3FqbcJErRDbjoxUkK9-c130_provenance.
• assertion description "[These data demonstrate elevated expression of COX-2 in a high percentage of high-grade bladder carcinomas, suggesting a possible role of COX-2 in the progression of bladder urothelial carcinoma and supporting its potential as a therapeutic target in human bladder carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These data demonstrate elevated expression of COX-2 in a high percentage of high-grade bladder carcinomas, suggesting a possible role of COX-2 in the progression of bladder urothelial carcinoma and supporting its potential as a therapeutic target in human bladder carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These data demonstrate elevated expression of COX-2 in a high percentage of high-grade bladder carcinomas, suggesting a possible role of COX-2 in the progression of bladder urothelial carcinoma and supporting its potential as a therapeutic target in human bladder carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[These data demonstrate elevated expression of COX-2 in a high percentage of high-grade bladder carcinomas, suggesting a possible role of COX-2 in the progression of bladder urothelial carcinoma and supporting its potential as a therapeutic target in human bladder carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP657918.RAkP6NeYWdsOX4VYy8lPSvKiQO5Qu02NDqY2rDSOwNsn8130_assertion description "[These data demonstrate elevated expression of COX-2 in a high percentage of high-grade bladder carcinomas, suggesting a possible role of COX-2 in the progression of bladder urothelial carcinoma and supporting its potential as a therapeutic target in human bladder carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657918.RAkP6NeYWdsOX4VYy8lPSvKiQO5Qu02NDqY2rDSOwNsn8130_provenance.
• NP288084.RAh4UYSwh8b7RVrVelUeblYLd9z9KvlVZNnRibMGIUj2g130_assertion description "[These data demonstrate elevated expression of COX-2 in a high percentage of high-grade bladder carcinomas, suggesting a possible role of COX-2 in the progression of bladder urothelial carcinoma and supporting its potential as a therapeutic target in human bladder carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288084.RAh4UYSwh8b7RVrVelUeblYLd9z9KvlVZNnRibMGIUj2g130_provenance.
• NP573807.RAlRtMjoYA_r2_36w_5TlNh_lxMVc4RabbWuLfHZ-keIs130_assertion description "[These data demonstrate elevated expression of COX-2 in a high percentage of high-grade bladder carcinomas, suggesting a possible role of COX-2 in the progression of bladder urothelial carcinoma and supporting its potential as a therapeutic target in human bladder carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573807.RAlRtMjoYA_r2_36w_5TlNh_lxMVc4RabbWuLfHZ-keIs130_provenance.